Literature DB >> 12480678

Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab.

F G Matzkies1, B Manger, M Schmitt-Haendle, T Nagel, H-G Kraetsch, J R Kalden, H Schulze-Koops.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12480678      PMCID: PMC1754301          DOI: 10.1136/ard.62.1.81

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Sweet's syndrome after adalimumab therapy for refractory relapsing polychondritis.

Authors:  Sarah Keidel; Aubretia McColl; Sally Edmonds
Journal:  BMJ Case Rep       Date:  2011-12-21

Review 2.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 3.  Anti-tumour necrosis factor-alpha therapy for rheumatoid and other inflammatory arthropathies: update on safety in older patients.

Authors:  Paul Ornetti; Hélène Chevillotte; Amal Zerrak; Jean Francis Maillefert
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Relapsing polychondritis: state of the art on clinical practice guidelines.

Authors:  Simona Rednic; Laura Damian; Rosaria Talarico; Carlo Alberto Scirè; Alexander Tobias; Nathalie Costedoat-Chalumeau; David Launay; Alexis Mathian; Lisa Mattews; Cristina Ponte; Paola Toniati; Stefano Bombardieri; Charissa Frank; Matthias Schneider; Vanessa Smith; Maurizio Cutolo; Marta Mosca; Laurent Arnaud
Journal:  RMD Open       Date:  2018-10-18

Review 5.  Insights Into the Pathogenesis of Sweet's Syndrome.

Authors:  Michael S Heath; Alex G Ortega-Loayza
Journal:  Front Immunol       Date:  2019-03-12       Impact factor: 7.561

Review 6.  Sweet's syndrome--a comprehensive review of an acute febrile neutrophilic dermatosis.

Authors:  Philip R Cohen
Journal:  Orphanet J Rare Dis       Date:  2007-07-26       Impact factor: 4.123

Review 7.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.